Quantifying the Impact of Influenza Among Persons With Type 2 Diabetes Mellitus: A New Approach to Determine Medical and Physical Activity Impact.
consumer wearable devices
diabetes mellitus
health outcomes
influenza infection
patient generated health data
Journal
Journal of diabetes science and technology
ISSN: 1932-2968
Titre abrégé: J Diabetes Sci Technol
Pays: United States
ID NLM: 101306166
Informations de publication
Date de publication:
01 2021
01 2021
Historique:
pubmed:
22
11
2019
medline:
29
10
2021
entrez:
22
11
2019
Statut:
ppublish
Résumé
We describe the impact of influenza on medical outcomes and daily activities among people with and without type 2 diabetes mellitus (T2DM). Retrospective cohort analysis of a US health plan offering a digital wellness platform connecting wearable devices capable of tracking steps, sleep, and heart rate. For the 2016 to 2017 influenza season, we compared adults with T2DM to age and gender matched controls. Medical claims were used to define cohorts and identify influenza events and outcomes. Digital tracking data were aggregated at time slices of minute-, day-, week-, and year-level. A pre-post study design compared the peri-influenza period (two weeks before and four weeks after influenza diagnosis) to the six-week preceding period (baseline). A total of 54 656 T2DM and 113 016 non-DM controls were used for the study. People with T2DM had more influenza claims, vaccinations, and influenza antivirals per 100 people (1.96% vs 1.37%, 34.3% vs 24.3%, and 27.1 vs 22 respectively, Influenza increases rates of pneumonia, heart disease, and abnormal glucose levels among people with T2DM, and negatively impacts daily activities compared to controls.
Sections du résumé
BACKGROUND
We describe the impact of influenza on medical outcomes and daily activities among people with and without type 2 diabetes mellitus (T2DM).
METHODS
Retrospective cohort analysis of a US health plan offering a digital wellness platform connecting wearable devices capable of tracking steps, sleep, and heart rate. For the 2016 to 2017 influenza season, we compared adults with T2DM to age and gender matched controls. Medical claims were used to define cohorts and identify influenza events and outcomes. Digital tracking data were aggregated at time slices of minute-, day-, week-, and year-level. A pre-post study design compared the peri-influenza period (two weeks before and four weeks after influenza diagnosis) to the six-week preceding period (baseline).
RESULTS
A total of 54 656 T2DM and 113 016 non-DM controls were used for the study. People with T2DM had more influenza claims, vaccinations, and influenza antivirals per 100 people (1.96% vs 1.37%, 34.3% vs 24.3%, and 27.1 vs 22 respectively,
CONCLUSION
Influenza increases rates of pneumonia, heart disease, and abnormal glucose levels among people with T2DM, and negatively impacts daily activities compared to controls.
Identifiants
pubmed: 31747789
doi: 10.1177/1932296819883340
pmc: PMC7780362
doi:
Substances chimiques
Hypoglycemic Agents
0
Types de publication
Journal Article
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
44-52Références
Wkly Epidemiol Rec. 2012 Nov 23;87(47):461-76
pubmed: 23210147
JAMA. 1999 Mar 10;281(10):901-7
pubmed: 10078486
Clin Infect Dis. 2014 Mar;58(6):775-84
pubmed: 24352349
Am J Physiol Regul Integr Comp Physiol. 2017 Mar 1;312(3):R358-R367
pubmed: 28052867
J Med Internet Res. 2012 Oct 04;14(5):e125
pubmed: 23037553
Diabetes Res Clin Pract. 1991 Apr;12(1):61-8
pubmed: 1906798
Vaccine. 2019 Jul 26;37(32):4594-4600
pubmed: 29699784
Sci Rep. 2017 Jun 12;7(1):3216
pubmed: 28607474
Lancet. 2003 Nov 22;362(9397):1733-45
pubmed: 14643124
Clin Infect Dis. 2014 Jan;58(2):214-24
pubmed: 24186906
Vaccine. 2017 Sep 12;35(38):5095-5101
pubmed: 28807608
Heart. 2015 Nov;101(21):1738-47
pubmed: 26310262
Diabetes Care. 2010 Jul;33(7):1491-3
pubmed: 20587722
N Engl J Med. 2018 Jan 25;378(4):345-353
pubmed: 29365305
Vaccine. 2018 Jun 22;36(27):3960-3966
pubmed: 29801998
PLoS One. 2011 Apr 27;6(4):e18687
pubmed: 21556151
Sensors (Basel). 2016 May 05;16(5):
pubmed: 27164110
J Med Internet Res. 2016 Sep 07;18(9):e239
pubmed: 27604226
Clin Infect Dis. 2018 Jun 18;67(1):8-17
pubmed: 29324996
Lancet. 2018 Mar 31;391(10127):1285-1300
pubmed: 29248255
J Diabetes Sci Technol. 2018 Jan;12(1):199-201
pubmed: 28539086
Ther Innov Regul Sci. 2017 Jul;51(4):468-470
pubmed: 30227056
MMWR Recomm Rep. 2013 Sep 20;62(RR-07):1-43
pubmed: 24048214
Heart. 2016 Dec 15;102(24):1953-1956
pubmed: 27686519
Diabetologia. 2014 Apr;57(4):690-8
pubmed: 24496923